Morgan Stanley Reiterates Overweight on Compass Pathways, Maintains $17 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.9%

Neg 0% Neu 86.9% Pos 0%

Morgan Stanley analyst Judah Frommer reiterates Compass Pathways (NASDAQ:CMPS) with a Overweight and maintains $17 price target.